Biopharma News : Biopharma and Pharma news from all around the world :
- Optime Care Launches First-in-Class, Novel Copay Assistance Program, Uses Block-Chain Technology to Address Drug Manufacturer Partners’ Challenges
- Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods
- New Research Shows Patient Proximity to Primary Care, Pharmacies Linked With Mental and Overall Health Satisfaction
- Global Head and Neck Cancer Therapeutics Market Report 2022: Diagnostic Methods v/s Treatment Type – Forecast to 2027 – ResearchAndMarkets.com
- Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2022
- End Drug Shortages Alliance Releases Market Assessment for Drugs Impacted by Manufacturing Plant Closure
- Labcorp to Speak at the UBS 2022 Global Healthcare Conference
- Biogennix’s DirectCell Advanced Bone Grafting System Used in 500th Case
- Transgene Announces Upcoming Investor Meetings
- Poxel Announces PXL065 and PXL770 Granted Orphan Drug Designation from the U.S. FDA for X-Linked Adrenoleukodystrophy
- New Milestone Clinical Study Shows Postbiotic Urolithin A (Mitopure™) Improves Muscle Strength and Exercise Performance in Middle Aged Adults
- Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference
- Mixlab Appoints Healthcare Operations Veteran as First Chief Operating Officer to Support National Expansion
- AscellaHealth Awarded as One of The Financial Times’ “Americas’ Fastest Growing Companies 2022” For Contribution to North and South America’s Economic Growth
- SpotSee Rolls Out New Tilt Monitor, TiltWatch RFID
- Julien Bradley Joins CellChorus as Advisor
- Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Health
- Transaction Data Systems Releases $2 Million for Refill Programs to Pharmacy Network
- Welldoc Earns 2022 Great Place to Work Certification™
- Hinge Health Releases 2022 State of Musculoskeletal Health Report
- Health Leaders Urge Immediate Action on Patient and Workforce Safety
- Nimble Therapeutics Announces Achievement of Development Milestones From Multiple Partnered Programs Connected to a Strategic Large Pharma Collaboration
- AppliedVR Partners with Kernel to Measure Brain Activity Changes Before, During, and After Virtual Reality (VR) Treatment of Chronic Pain
- Lassen Therapeutics Presents Data Demonstrating Preclinical Anti-fibrotic Effect of LASN01, a Novel IL-11 Receptor-Blocking Antibody, at the American Thoracic Society 2022 Annual Meeting
- Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting
- ZS and Quartic to Accelerate Manufacturing Digitalization in Life Sciences and Healthcare
- Oak Hill Bio Appoints Tauhid Ali as First Chief Executive Officer
- Civetta Therapeutics Appoints Jesse Smith, Ph.D. as CSO and Susan Ashwell, Ph.D. as SVP of Chemistry
- Exo Therapeutics Appoints Stephanos Ioannidis as Executive Vice President, Drug Discovery and Catherine Scholz as Senior Vice President, Program Management
- Epizyme To Participate in H.C. Wainwright Global Investment Conference
Biotech – Biopharma News!
- United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) grants Marketing Authorization for FYB201, Formycon’s Biosimilar for Lucentis®1 to be Commercialized by Teva as ONGAVIA®
- FYB201, Formycon’s Biosimilar for Lucentis®1 achieves Marketing Authorization in United Kingdom
- Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a ‘functional cure’ for diabetes
- PharmaSGP: Another revenue record – Q1 2022 revenues up 67% year-on-year
- Original-Research: Defence Therapeutics Inc. (von GBC AG)
- Gerresheimer AG: Gerresheimer executes on its growth strategy in Emerging Markets boosting capacities in India
- Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project
- Q1/2022: Solid start to the year with 6 % sales growth and EBITDA within expectations in a challenging macroeconomic environment
- APONTIS PHARMA holds Annual General Meeting 2022 – shareholders approve all agenda items with large majorities
- Biophytis: Biophytis announces its participation at the BIO International Convention in San Diego from the 13th to the 16th of June
- RHÖN-KLINIKUM Aktiengesellschaft: Financial year 2022 again marked by COVID-19 pandemic
- Eckert & Ziegler with Sales Growth in the First Quarter of 2022
- Spexis to present at BioEquity Europe 2022
- Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil
- SYNLAB reports a strong start to the fiscal year 2022
- Geratherm Medical AG: Voluntary delisting offer by JotWe GmbH published
- Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
- Epigenomics AG Reports Financial Results for the First Quarter of 2022
- Medios AG: Revenue and earnings at record levels in the first quarter
- Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Hold its Annual General Meeting on June 22, 2022 (news with additional features)
- Evotec SE reports results for the first quarter 2022 and provides corporate update
- Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
- Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation
- Evotec and Bristol Myers Squibb extend and expand strategic partnership
- SYNLAB AG: SYNLAB Medical Congress: making healthcare future-proof with advanced diagnostics
- APONTIS PHARMA continues strong profitable growth in Q1 2022
- Formycon AG and ATHOS KG announce closing of transaction to acquire biosimilar assets FYB201 and FYB202 as well as Bioeq GmbH
- Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU) No. 2016/1052 and Article 5 (1) Regulation (EU) No 2014/596 (Market Abuse Regulation)
- Heidelberg Pharma AG and Partner Huadong Receive all Approvals for the Announced Transaction from the Authorities and Plan Capital Measure
- Gerresheimer AG: Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution
- Extendicare Completes Sale of Esprit Retirement Communities
- Sienna Senior Living Completes Acquisition of 50% Ownership Interest in 11 Properties in Ontario and Saskatchewan
- Sorrento’s License Partner, Lee’s Pharm, Announces Full Enrollment of 498 Patients in a Phase III Trial of Socazolimab (Anti-PD-L1 Antibody) for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
- Steering committee of pulmonary and primary care experts aims to reduce time to diagnose complex lung diseases
- Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
- H1 and Lightship Partner to Accelerate Clinical Studies with Diversity, Equity, and Inclusion Data
- Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
- Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial)
- Icario/Harris Poll Survey Uncovers Challenges Associated with Educating Medicaid Members on Redetermination and Re-enrollment
- Virax Biolabs Introduces New Board of Directors, Announces Members
- OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth
- New informational website around larynx cancer surgery
- Nexstim agrees with Dr. Joshua Kuluva on a minority interest in the private equity company established previously
- Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery
- ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update
- Dr. James Fleckenstein Scholarship for Future Medical Doctors Accepting Applications
- Mydecine Announces First Quarter 2022 Financial Results and Highlights
- Allarity Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
- OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing
- ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
- Skylight Health Group Reports First Quarter 2022 Financial Results
- Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
- Quipt Home Medical Reports Record Second Quarter Fiscal 2022 Financial Results
- Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT
- AnPac Bio Reports Fiscal Year 2021 Annual Financial Results
- Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
- LeMaitre to Present at Upcoming Investor Conferences
- Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
- BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News